\documentclass[10pt,a4paper]{article}

% Packages
\usepackage{fancyhdr}           % For header and footer
\usepackage{multicol}           % Allows multicols in tables
\usepackage{tabularx}           % Intelligent column widths
\usepackage{tabulary}           % Used in header and footer
\usepackage{hhline}             % Border under tables
\usepackage{graphicx}           % For images
\usepackage{xcolor}             % For hex colours
%\usepackage[utf8x]{inputenc}    % For unicode character support
\usepackage[T1]{fontenc}        % Without this we get weird character replacements
\usepackage{colortbl}           % For coloured tables
\usepackage{setspace}           % For line height
\usepackage{lastpage}           % Needed for total page number
\usepackage{seqsplit}           % Splits long words.
%\usepackage{opensans}          % Can't make this work so far. Shame. Would be lovely.
\usepackage[normalem]{ulem}     % For underlining links
% Most of the following are not required for the majority
% of cheat sheets but are needed for some symbol support.
\usepackage{amsmath}            % Symbols
\usepackage{MnSymbol}           % Symbols
\usepackage{wasysym}            % Symbols
%\usepackage[english,german,french,spanish,italian]{babel}              % Languages

% Document Info
\author{pennyoscar19}
\pdfinfo{
  /Title (test-2.pdf)
  /Creator (Cheatography)
  /Author (pennyoscar19)
  /Subject (Test 2 Cheat Sheet)
}

% Lengths and widths
\addtolength{\textwidth}{6cm}
\addtolength{\textheight}{-1cm}
\addtolength{\hoffset}{-3cm}
\addtolength{\voffset}{-2cm}
\setlength{\tabcolsep}{0.2cm} % Space between columns
\setlength{\headsep}{-12pt} % Reduce space between header and content
\setlength{\headheight}{85pt} % If less, LaTeX automatically increases it
\renewcommand{\footrulewidth}{0pt} % Remove footer line
\renewcommand{\headrulewidth}{0pt} % Remove header line
\renewcommand{\seqinsert}{\ifmmode\allowbreak\else\-\fi} % Hyphens in seqsplit
% This two commands together give roughly
% the right line height in the tables
\renewcommand{\arraystretch}{1.3}
\onehalfspacing

% Commands
\newcommand{\SetRowColor}[1]{\noalign{\gdef\RowColorName{#1}}\rowcolor{\RowColorName}} % Shortcut for row colour
\newcommand{\mymulticolumn}[3]{\multicolumn{#1}{>{\columncolor{\RowColorName}}#2}{#3}} % For coloured multi-cols
\newcolumntype{x}[1]{>{\raggedright}p{#1}} % New column types for ragged-right paragraph columns
\newcommand{\tn}{\tabularnewline} % Required as custom column type in use

% Font and Colours
\definecolor{HeadBackground}{HTML}{333333}
\definecolor{FootBackground}{HTML}{666666}
\definecolor{TextColor}{HTML}{333333}
\definecolor{DarkBackground}{HTML}{A3A3A3}
\definecolor{LightBackground}{HTML}{F3F3F3}
\renewcommand{\familydefault}{\sfdefault}
\color{TextColor}

% Header and Footer
\pagestyle{fancy}
\fancyhead{} % Set header to blank
\fancyfoot{} % Set footer to blank
\fancyhead[L]{
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{C}
    \SetRowColor{DarkBackground}
    \vspace{-7pt}
    {\parbox{\dimexpr\textwidth-2\fboxsep\relax}{\noindent
        \hspace*{-6pt}\includegraphics[width=5.8cm]{/web/www.cheatography.com/public/images/cheatography_logo.pdf}}
    }
\end{tabulary}
\columnbreak
\begin{tabulary}{11cm}{L}
    \vspace{-2pt}\large{\bf{\textcolor{DarkBackground}{\textrm{Test 2 Cheat Sheet}}}} \\
    \normalsize{by \textcolor{DarkBackground}{pennyoscar19} via \textcolor{DarkBackground}{\uline{cheatography.com/155068/cs/33164/}}}
\end{tabulary}
\end{multicols}}

\fancyfoot[L]{ \footnotesize
\noindent
\begin{multicols}{3}
\begin{tabulary}{5.8cm}{LL}
  \SetRowColor{FootBackground}
  \mymulticolumn{2}{p{5.377cm}}{\bf\textcolor{white}{Cheatographer}}  \\
  \vspace{-2pt}pennyoscar19 \\
  \uline{cheatography.com/pennyoscar19} \\
  \end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Cheat Sheet}}  \\
   \vspace{-2pt}Not Yet Published.\\
   Updated 15th July, 2022.\\
   Page {\thepage} of \pageref{LastPage}.
\end{tabulary}
\vfill
\columnbreak
\begin{tabulary}{5.8cm}{L}
  \SetRowColor{FootBackground}
  \mymulticolumn{1}{p{5.377cm}}{\bf\textcolor{white}{Sponsor}}  \\
  \SetRowColor{white}
  \vspace{-5pt}
  %\includegraphics[width=48px,height=48px]{dave.jpeg}
  Measure your website readability!\\
  www.readability-score.com
\end{tabulary}
\end{multicols}}




\begin{document}
\raggedright
\raggedcolumns

% Set font size to small. Switch to any value
% from this page to resize cheat sheet text:
% www.emerson.emory.edu/services/latex/latex_169.html
\footnotesize % Small font.

\begin{multicols*}{4}

\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Patho - Test 2}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Week 4 - AS}} \{\{nl\}\} Disorders of Arterial Circulation\{\{nl\}\} 1. Hyperlipidemia - an increase in blood cholesterol as chol. and tri. increase, so does HD \& stroke \{\{nl\}\} 2. Atherosclerosis - plaque buildup in arteries \{\{nl\}\} 3. Occlusions/Obstructions - complete or partial bloackage in b.v (veins or arteries)} \tn 
% Row Count 7 (+ 7)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{5 Lipoproteins}} \{\{nl\}\} 1.Chylomicrons 2. VLDL 3. IDL \{\{nl\}\} 4. {\bf{LDL}} - too much fat -{}-\textgreater{} liver saturated -{}-\textgreater{} too much in blood -{}-\textgreater{} excess LDL binds to endothelial cells -{}-\textgreater{} macrophages bind to LDL -{}-\textgreater{} m.p oxidize LDL (key contributor to AS)  \{\{nl\}\} 5. {\bf{HDL}} - "good" \& synthesized by liver - transports chol back to liver from periphery} \tn 
% Row Count 14 (+ 7)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{CAD RISK FACTORS}} \{\{nl\}\} *smoking * HTN * family hx * HDL less than 40mg/dL * diabetes} \tn 
% Row Count 16 (+ 2)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Atherosclerosis}} \{\{nl\}\} Accumulation of lipid-laden macrophages forming a lesion called plaque \{\{nl\}\} Leading cause: CAD, stroke, peripheral arterial disease \{\{nl\}\} {\bf{RISK FACTORS AS}} \{\{nl\}\} increasing age, male, genetic disorders of metabolism, family hx of CAD OR smoking, obesity, HTN, HYLIP, diabetes} \tn 
% Row Count 23 (+ 7)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Pathogensis of AS}} \{\{nl\}\} 1. Endothelial Injury - smoking, LDL, immune mechanisms \& mechanical stress from HTN cause this with adhesion of monocytes and platelets \{\{nl\}\} 2. Migration of inflammatory cells - endothelial cells bind to monocytes and platelets that start AS lesions - monoctyes adhere to endothelium and stay in intima, transform into macrophages and engulf LDLs \{\{nl\}\} 3. Lipid Accumulation \& SM proliferation - macrophages engulf LDL (protects but contributes to AS) \& activated macrophages release toxic o2 that oxidizes LDL. Oxidized LDL ingested by macrophages result in FOAM CELLS \{\{nl\}\} 4.Gradual development of plaque - consists of smooth muscle cells aggregation, macrophages, ECM, lipids. Superficial fibrous cap = SMC's and dense ECM} \tn 
% Row Count 39 (+ 16)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Patho - Test 2 (cont)}}  \tn
% Row 5
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Plaque Structure}} \{\{nl\}\} {\bf{shoulder}} consists of macrophages, SMC's \& lymphocytes \{\{nl\}\} Central core = lipid laden foam cells and fatty debris \{\{nl\}\} Rupture or erosion of unstable fibrous cap can lead to hemorrhage into plaque or thrombotic occlusion in vessel lumen \{\{nl\}\} {\bf{STABLE}} thick fibrous cap, partially blocked vessels, no clot formation or emboli \{\{nl\}\} {\bf{UNSTABLE}} thin fibrous cap, completely block artery, can rupture = thrombus or embolus} \tn 
% Row Count 10 (+ 10)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 6 - Cerebrovascular Disease}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{TERMS}} \{\{nl\}\} {\bf{Tissue Perfusion}}: process of blood to a cap. bed in tissue "pour over or through" - blood flow \{\{nl\}\} {\bf{Aneurysm}} abnormal bulging of arterial wall, worsens over time as blood pushes against it, eventually bursting \{\{nl\}\} {\bf{Ischemia}}: low flow of blood to tissues and causes damage to target tissues (via obstruction or hemorrhage)  \{\{nl\}\} {\bf{Embolism}} blockage forms clot and moves through circ.} \tn 
% Row Count 9 (+ 9)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Stroke}}: acute focal neurological deficit from vascular impairment of cerebral blood flow (\textgreater{} tissue perf \& ischemia -{}-\textgreater{} neurological deficits) \{\{nl\}\} 2 types {\bf{ISCHEMIC}} (caused by thrombosis/emboli) \& {\bf{HEMORRHAGIC}} (subarachnoid anuerysmal hemorrhage)} \tn 
% Row Count 15 (+ 6)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Ischemic Stroke}} \{\{nl\}\} risk factors: HTN, smoking, diabetes, carotis stenosis, sickle cell diease, hyperlipidemia, atrial fibrillation \{\{nl\}\} 5 stoke subtypes: 1. large artery AS disease, 2. small vessel or pen. artery, 3. cardiogenic embolism 4. cryptogenic stroke 5. unusual causes} \tn 
% Row Count 21 (+ 6)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Penumbra}} central core of dead/dying cells surrounded by ischemic band of cells called "penumbra" HALO. \{\{nl\}\} cells inside penumbra experience: impaired metabolic activity, eletrical failure, structural intg. cells maintained\{\{nl\}\} Survival is dependant on return of circ. \{\{nl\}\} {\bf{will remain viable for several hrs due to collateral arteries supplying the zone}}} \tn 
% Row Count 29 (+ 8)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{LARGE vessel (thrombotic) Stroke}} \{\{nl\}\} thrombi most common cause of ischemic stroke in AS vessels (common sites: internal carotid, veterbral arteries, junctions at basilar and vertebral, arterial bifurcations) \{\{nl\}\} {\bf{Affects}} - cerebral cortex as APHASIA \& neglect as VISUAL \& UNILATERAL} \tn 
% Row Count 35 (+ 6)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 6 - Cerebrovascular Disease (cont)}}  \tn
% Row 5
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{SMALL vessel (lacunar infarct) Stroke}} \{\{nl\}\} small infarcts located deep in brain result from occlusion of smaller penetrating branches of larger cerebral arteries \{\{nl\}\}- healing lucunar ifarcts leave behind lacunae (small cavities from AS) \{\{nl\}\} {\bf{Affects}} - hemiplegia, dysarthia (weakness of hands), MRI to diagnose} \tn 
% Row Count 7 (+ 7)
% Row 6
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{TIA}} - "ministroke* where blood flow reverses before infarction occurs (1 hr symptoms), zone of penumbra, caused by AS, warning} \tn 
% Row Count 10 (+ 3)
% Row 7
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Cardiogenic Embolic Stroke}} caused by moving blood clot that travels from its origin to brain, frequently in middle cerebral artery, originate from heart, SUDDEN} \tn 
% Row Count 14 (+ 4)
% Row 8
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Homonymous Hemianopsia - food on left side not seen}}} \tn 
% Row Count 16 (+ 2)
% Row 9
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Diagnosis of Acute Stroke}} \{\{nl\}\} CT, MRIs, catheter based conventional arteriography, sonography\{\{nl\}\} {\bf{Treatment}} GOALS: saving tissue, preventing secondary stroke, min. long-term disability -{}-{}- reperfusion tech. like tPA, catheter-directed clot distruption, aug. of CPP \{\{nl\}\} {\bf{Post MGMT}} highest risk 1 week after stroke or TIA, anti-platelet agents, warfarin} \tn 
% Row Count 24 (+ 8)
% Row 10
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{HEMORRHAGIC STROKE}} \{\{nl\}\} - often fatal - rupture of b.v - hemorrhage in brain tissue - compression in brain tissue by expanding hematoma and tissue edema in brain \{\{nl\}\} {\bf{most common is aneurysmal subarachnoid hemorrhage (SAH) \{\{nl\}\} }}Risk Factors** - age, HTN, aneurysm, trauma, tumors, blood coag. disorders, drugs etc} \tn 
% Row Count 31 (+ 7)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 6 - Cerebrovascular Disease (cont)}}  \tn
% Row 11
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Manifestations}} 1. vomiting/headache 2. contralateral hemiplegia (hemorrhage into basal ganglia) 3. Edema exert pressure = coma \& death {\bf{(monro-kellie hypothosis)}}} \tn 
% Row Count 4 (+ 4)
% Row 12
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{SAH}}: arise from congenital defect in medial layers of involved vessels - rupture of aneurysm casues bleeding into SA space leads to increased ICP} \tn 
% Row Count 7 (+ 3)
% Row 13
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Manifestation of SAH}} BEFORE: asymptomatic, history of headaches, chronic headache AFTER: sudden headache, LOC, vomiting, blurred vision, sensory deficits, HTN, cerebral edema \{\{nl\}\}  Diagnosis: clinical, CT scan, vascular imaging, lumbar puncture} \tn 
% Row Count 12 (+ 5)
% Row 14
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{VASOSPASM}}: involves focal narrowing of cerebral arteries - decreasing neurological status due to blood loss to area, 3-10 days after rupture \{\{nl\}\}  {\bf{treatment}} - vasoactive drugs, IV fluid, risk of re-bleeding, balloon dilation, meds (nimodipine)} \tn 
% Row Count 18 (+ 6)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Patho - Test 2}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Week 4 - HTN}} \{\{nl\}\} o most common health problem\{\{nl\}\} o leading risk factor for CV disorders (creates AS, increases workload on heart in left ventricular hypertrophy)\{\{nl\}\} o more men\{\{nl\}\} {\bf{BP = CO x SVR}} \{\{nl\}\}} \tn 
% Row Count 5 (+ 5)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Complications}} \{\{nl\}\} high BP marked with progressive target organ damage (180/120) \{\{nl\}\} w/ severe headache/cerebral edema \{\{nl\}\} {\bf{Treatment}} partial reduction in bp to safer level} \tn 
% Row Count 9 (+ 4)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Special Pops}} \{\{nl\}\} Pregnancy - preclampsia-eclampsia \{\{nl\}\} Children/adolescents - lifestyle or secondary HTN (kidney issues) \{\{nl\}\} Older adults - stiffening of large arteries} \tn 
% Row Count 13 (+ 4)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Week 4 - Cardiac Conditions}} \{\{nl\}\} {\bf{CAD}}: Heart disease cause by impaired coronary blood flow (AS most common cause) \{\{nl\}\} {\bf{Pathogenesis of CAD}} \{\{nl\}\} no symptoms until advances b/c collateral flow \{\{nl\}\} lesions usually located in LAD and RCA} \tn 
% Row Count 19 (+ 6)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{CAD - 2 types}} \{\{nl\}\} {\bf{1. ACS}} - acute plaque disruption (unstable angina to MI) \& presence of ST segment elevation present to confirm, T wave inversion, abnorm. Q wave\{\{nl\}\} {\bf{Diagnosis of ACS}} troponin I \& troponin T (PRIMARY - rise 3 hr post MI and last 7-10 days), myoglobin, CKMB  \{\{nl\}\} {\bf{2. Chronic ischemic heart diease}} - AS or vasospatic obstruction of coronary artery (ie, stable angina) \{\{nl\}\} Stable Plaque = stable angina \{\{nl\}\} Unstable Plaque = pl. disruption, platelet agg, thrombus, unstable angina \& MI \{\{nl\}\} {\bf{Pathophysiology of MI}} Occlusion -{}-\textgreater{}contractibility stops depriving myocardial cells -{}-\textgreater{} LA accumulates and fibres irritated -{}-\textgreater{} angina -{}-\textgreater{} lead to MI} \tn 
% Row Count 33 (+ 14)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Patho - Test 2 (cont)}}  \tn
% Row 5
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Chronic Stable Angina}} \{\{nl\}\} {\bf{Angina Pectoris}}"sudden attack of angina due to transient myoc. ischemia \{\{nl\}\} PRIMARY MANIFESTATION IS {\bf{PAIN}} \{\{nl\}\}} \tn 
% Row Count 4 (+ 4)
% Row 6
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{MI}} \{\{nl\}\} {\bf{STEMI}}: ischemic death of myocardial tissue occurs when a ruptured plaque blocks a major artery completely. - ST elevation. \{\{nl\}\} {\bf{Unstable Angina/NSTEMI}}: caused by a block in a minor artery or a partial obstruction in a major artery. More severe prolonged angina \{\{nl\}\} {\bf{STEMI - Referfusion}}: Reestablish blood flow w/fibrinolytic therapy {\bf{BENEFITS}} - prevent necrosis, improve mycar. perfusion (recovery called stunned) \{\{nl\}\} {\bf{Treatment of AMI}} firbinolytic therapy, PCI \& CABG} \tn 
% Row Count 15 (+ 11)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 7 - Respiratory Conditions Part 1}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{PULMONARY EDEMA}} \{\{nl\}\} cap fluit move to alveoli, hgb leaves = cyanosis, coughing, crackles, tachycardia, cool skin \{\{nl\}\}  {\bf{treatment}} - non pharm: o2 and assistance with breathing -{}- pharm: diuretics, ACE inhibitors} \tn 
% Row Count 5 (+ 5)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{PNEUMOTHORAX}} \{\{nl\}\} presence of air in pleural space, causes partial or full collapse \{\{nl\}\}  {\bf{1. Spontaneous}} rupture of bleb on surface of lung, allows air from airways to enter pleural space, higher alveolar pressure and air flows into space, collapse\{\{nl\}\} {\bf{primary}}:healthy, belbs at top, smoking \{\{nl\}\} {\bf{secondary}}:pt with lung disease, can be life threatening \{\{nl\}\} {\bf{2. Traumatic}} caused by penetrating or non-penetrating chest injuries (fracture ribs) \{\{nl\}\}  {\bf{3. Tension}} life-threatening condition where injury allows air to enter but not leave, opposite side compression, shift in mediastinum, compression in vena cava, decrease in venous return to heart and decrease CO\{\{nl\}\} {\bf{diagnosis}} - clinical and xray CT \{\{nl\}\} {\bf{treatment}} small pnuemothroaces, o2, need apsiration} \tn 
% Row Count 22 (+ 17)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{HEMOTHORAX}} presence of blood in plueral space - all same as penuemothorax} \tn 
% Row Count 24 (+ 2)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{ASTHMA}} \{\{nl\}\} 1. Expose to allergin - mast cells release inflammatory mediators (symp. 10-20 min) 2. Infiiltration of WBCs - release of cytokins (increased mucous) 3. Bronchospasm - caused by stim. of PS receptors, mucosal edema \{\{nl\}\}  {\emph{late phase}} 1. Inflammation and increased airway responsiveness (4-8 hrs after exposure) 2. Release of inflamm. mediators from mast cells (induce migration and basophil activation) 3. Epithelial injury and increase vascular permeability (edema) 4. Bronchospasm \{\{nl\}\}  {\bf{treatment}} SABA or LABA, brochidilators (b2 agonists, anticholinergic agents), steroids, aerochamber more effective} \tn 
% Row Count 37 (+ 13)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 7 - Respiratory Conditions Part 1 (cont)}}  \tn
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{COPD (emphysema \& chronic brochitis)}} \{\{nl\}\} -chronic obstruction of lung airflow that interferes with normal breathing and not reversible \{\{nl\}\} - not cureable - \{\{nl\}\} {\bf{emphysema}}: enlargement of air spaces and destruction of lung tissues, a1 deficiency \{\{nl\}\}  {\bf{COB}}: obstruction of small airways, chronic irritation (smoking) \{\{nl\}\}  {\bf{patho}} increased mucous cells, mucous hypersecretion, hypertrophy in glands in trachea/bronchi, imflammation, fibrosis bronchiolar wall, increase goblet cells, viral and bacterial infections \{\{nl\}\} {\bf{clinical fts}} insidious onset, cough in am, dyspnea, SOB \{\{nl\}\}  {\bf{manifestations}} wheezes and crackles, tripod position, pursed lip breathing, hypoxemia, cyanosis} \tn 
% Row Count 15 (+ 15)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Emphysema Patho}} \{\{nl\}\}  increased neutrophils in alveoli secrete trypsin, and imbalance of tryspin and a1 decreases protection, elasrase triggers breakdown of elastin, which damages alveoli\{\{nl\}\}  smoke -{}-\textgreater{} inflammation -{}-\textgreater{} acti. neutrophils -{}-\textgreater{} inactiv. of antiproteases -{}-\textgreater{} increase elastase activity -{}-\textgreater{} tissue destruction} \tn 
% Row Count 22 (+ 7)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{PINK PUFFER}} - usually emphysema, increases resp to maintain o2, dyspnea, lip breathing {\bf{BLUE BLOATERS}} - usually bronchitis, cannot increase resp enough to maintain o2, cyanosis, cor pulmonale} \tn 
% Row Count 26 (+ 4)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 5 - Heart Failure (CHF)}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Heart Failure}} any structural or functional disorder of the heart w/ low CO \&/or pulmonary or systemic congestion \{\{nl\}\} {\bf{Common Causes}}: CAD, HTN, dilated cardiomyopathy, valvular HD} \tn 
% Row Count 4 (+ 4)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Heart as a pump}} \{\{nl\}\} {\bf{Preload}} - blood in ventricles at end of diastole right before ven. contract, blood pressure in l. vent. before contraction \{\{nl\}\} {\bf{Afterload}} - force of contracting heart muscles to eject blood, resistance in systole, {\bf{A}}fterload created by {\bf{A}}rteries \{\{nl\}\} {\bf{Contractibility}} - ability to contract, increases CO, ATP \& Ca+} \tn 
% Row Count 12 (+ 8)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Systolic dysfunction}} decreased contracting -{}-\textgreater{} decrease EF (less than 40\%) \{\{nl\}\} {\bf{Manifestations}} - increase in preload -{}-\textgreater{} blood accumlates in atria and pulmonary venous system -{}-\textgreater{} pulmonary congestions \{\{nl\}\} {\bf{Diastolic dysfunction}} - inability for l. ven. to fill during diastole. \{\{nl\}\} leads to increased pressure in left atrium -{}-\textgreater{} pulmonary congestion \& decrease lung compliance -{}-\textgreater{} CO is decreased bc decreased filling} \tn 
% Row Count 21 (+ 9)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Frank Starling Mechanism}} \{\{nl\}\} - end result is increased SV - preload (end diastolic volume) increases - cardiac muscle fibres stretch \& trigger stronger contraction - increases CV at lower HR} \tn 
% Row Count 25 (+ 4)
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Manifestations of CHF}} \{\{nl\}\} 1. impaired pumping 2. decreased renal blood flow 3. sympathetic nervous system \{\{nl\}\} {\bf{symptoms}} fluid retention, dyspnea, fatigue, cyanosis, malnutrition, arrhythmias} \tn 
% Row Count 30 (+ 5)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 5 - Heart Failure (CHF) (cont)}}  \tn
% Row 5
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Acute pulmonary edema}} \{\{nl\}\} cap. fluid moved into alveoli \{\{nl\}\} {\bf{SEVERE}} pulmonary edema due to elevated left ventricular filling pressures {\emph{decrease o2 supply to brain, confusion, dyspnea, frothy pink sputum, crackles}} \{\{nl\}\} {\bf{Treatment}} non-pharm: exercise, Na+ \& water restrictions, weight mgmt \{\{nl\}\} pharm: diuretics, digoxin, ACE inhibitors, beta-blockers \{\{nl\}\} others - o2, cardiac re-synchronization, ventricular assist devices} \tn 
% Row Count 9 (+ 9)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 8 - Respiratory Conditions Part 2}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Pneumonia}} \{\{nl\}\} TYPICAL: bacterial infection, inflammation and exudation of fluid into alveoli ATYPICAL: involves alveolar septum and interstitium of lung, ourulent sputum, leukicytosis\{\{nl\}\} {\bf{patho}} 1. aspiration 2. release of bacterial endotoxin 3. inflammatory response (neutrophils, fibrinous exudate, RBCs) 4. red hepatization and consol. of lung parenchyma -{}- leukocyte infilration -{}- 5. gray hepatization and depo. of fibrin, phagocytolsis of alveoli 6. resolution of infection (macrophages engulf neutro, fibrin and bacteria} \tn 
% Row Count 11 (+ 11)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Acute Bacterial (typical) Pneumonia}} \{\{nl\}\} 1. Pneumococcal pne. or streptococcus pne. - attaches and colonizes to mucosa, delays phagocytosis, acts as antigen \{\{nl\}\}  {\bf{onset}} malaise, shaking, chills, fever \{\{nl\}\} {\bf{initial stage}} cough, watery sputum, fine crackles \{\{nl\}\}  {\bf{progressive}} cough with purulent blood tinged sputum, lung pain with breathing\{\{nl\}\}  elderly = less likely to have temps (may only have loss of apetite or bad mental status)\{\{nl\}\} 2. Pneumococcal Pne. - vehicle transmission, impairs gas exhange, 2-10 days after infection, dirrhea \{\{nl\}\}  {\bf{manifestations}} malaise, weakness, lethargy, fever, dry cough} \tn 
% Row Count 24 (+ 13)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{atypical - lack of lung consolidation and alveolar exudate, less sputum, elevation of WBCS\{\{nl\}\} mycoplasma pne. common bacterial agent in children} \tn 
% Row Count 27 (+ 3)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{TB}} - slender rod-shaped bacilli that do not form spores\{\{nl\}\} {\bf{myobacterium}} waxy cell wall and responsible for: slow growth - ability to trigger immune response - rest. for \seqsplit{destruction/antibiotics/lab} stains \{\{nl\}\}  {\bf{patho}} inhaled droplet pass down bronchial tree and land in alveoli, bacilli are phag. by alveolar macro but resist killing, intitiate cell mediated immune response that contains infection, bacilli multiply, infect macrophaes, degrade myobacteria and present antigens on helper t lymphs.\{\{nl\}\}  INITIAL TB INFECTION - macro begin cell mediated response, results in granulomatous lesion (GHON FOCUS) containing macro, t cells and inactive TB bacteria \{\{nl\}\}{\bf{patho cont}} t helper cells stim. macro to increase and kill mycobacteria, when released they damage lung tissue, cytotoxic t cells and macro constitute the cell mediate response that takes 3-6 weeks to become effective} \tn 
% Row Count 46 (+ 19)
\end{tabularx}
\par\addvspace{1.3em}

\vfill
\columnbreak
\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 8 - Respiratory Conditions Part 2 (cont)}}  \tn
% Row 4
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Ghon Focus}}: area where organisms ends up in lungs turn gray granuloma (typically in upper seg. of lower lobes and lower seg. of upper lobes\{\{nl\}\} {\bf{Ghon Complex}}: undergoes soft necrosis, caseous granuloma form along lymph channels, later shrinks, becomes fibrous and calcified, visible with chest xray} \tn 
% Row Count 7 (+ 7)
% Row 5
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{primary TB}} - previous unexposed pt (inhale) - insidious symptoms: fever, weight loss, fatigue, night sweats abrupt onset: high fever, pleuritis and lympthadenitis \{\{nl\}\} {\bf{secondary TB}}: reinfection from inhaled droplets or reactivation with dry cough, low grade fever, productive blood tinged sputum} \tn 
% Row Count 14 (+ 7)
% Row 6
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{treatment of TB}} - eliminating bacilli in infected pt, preventing spread, antibioltics (INH and rifampin)} \tn 
% Row Count 17 (+ 3)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}

\begin{tabularx}{3.833cm}{X}
\SetRowColor{DarkBackground}
\mymulticolumn{1}{x{3.833cm}}{\bf\textcolor{white}{Week 5 - Peripheral Vascular Disease}}  \tn
% Row 0
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{PAD}} \{\{nl\}\} systemic AS distal to aorta w/ claudication, atrophic changes/thinning of skin, weak pedal pulse, ischemia pain, gangrene, ulcers on toes, ankles} \tn 
% Row Count 4 (+ 4)
% Row 1
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{Diagnostics}} \{\{nl\}\} - inspection of limbs, palp, pulses, ankle-brachial index, US, MRI, CT, angiography \{\{nl\}\} {\bf{Treatment}} \{\{nl\}\} - protection of area, walking to point of claudication, avoidance of injury, antiplatelets, surgery} \tn 
% Row Count 9 (+ 5)
% Row 2
\SetRowColor{LightBackground}
\mymulticolumn{1}{x{3.833cm}}{{\bf{PVD}} \{\{nl\}\} - manifested by venous HTN, causes reflux in veins, prolonged standing increases pressure and dilated vessel wall \{\{nl\}\} {\bf{Manifestations}} - tissue congestion, edema, necrosis of fat deposits, brown pigmentation, advanced (stasis dermatisis, ulcers ankles uneven) \{\{nl\}\} {\bf{Treatments}} - compression therapy, dressings, bandages} \tn 
% Row Count 16 (+ 7)
% Row 3
\SetRowColor{white}
\mymulticolumn{1}{x{3.833cm}}{{\bf{DVT or thrombophlebitis}} \{\{nl\}\} - presences of thrombus in vein w/ imflammatory response (calf) \{\{nl\}\} risk factors: VIRCHOWS TRIAD (blood stasis, hyperactivity of blood coag. vessel wall injury) \& increase risk with bad cardiac function\{\{nl\}\} - usually asymptomatic (if not, pain, swelling etc) U/S, tx is prevention, warfarin, IVC filter, complications - pulmonary embolism} \tn 
% Row Count 24 (+ 8)
\hhline{>{\arrayrulecolor{DarkBackground}}-}
\end{tabularx}
\par\addvspace{1.3em}


% That's all folks
\end{multicols*}

\end{document}